NCT05753020 A Pilot Study of The CKM JumpStart Tool
| NCT ID | NCT05753020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Chronic Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2023-04-10 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2023-04-10 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized pilot study to test the feasibility and acceptability of a tool to promote discussion about conservative kidney management (CKM) among older patients with advanced CKD and their providers.
Eligibility Criteria
Patients Inclusion: * Adults aged ≥75 years * Advanced CKD as defined as having at least 2 outpatient measures of eGFR \<25 ml/min/1.73m2 separated by \>90 days in the prior year and with at least 1 eGFR measure \<20. * English-speaking * Receive care from a provider at UW Medicine or VA Puget Sound * Open to discussing their values and treatment options for kidney disease with their provider. Exclusion: * Unable to complete the informed consent process * Currently receiving maintenance dialysis Providers Inclusion * Their patient is a participant in the study. * Are a UW Medicine or VA Puget Sound provider or trainee. Exclusion • None
Contact & Investigator
Susan P Wong, MD, MS
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT05753020 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05753020 currently recruiting?
Yes, NCT05753020 is actively recruiting participants. Contact the research team at ollyg@uw.edu for enrollment information.
Where is the NCT05753020 trial being conducted?
This trial is being conducted at Seattle, United States, Seattle, United States.
Who is sponsoring the NCT05753020 clinical trial?
NCT05753020 is sponsored by University of Washington. The principal investigator is Susan P Wong, MD, MS at University of Washington. The trial plans to enroll 76 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.